Software Acquisition Group III, the third blank check company led by former Ooyala officers targeting a software company, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-half of a warrant,...read more
Software Acquisition Group II, the second blank check company led by former Ooyala officers targeting a software company, raised $150 million by offering 15 million units at $10. Each unit consists of one share of the common stock and one-half of one...read more
Three drug developers and a medical imaging company went public this past week, joined by eight SPACs. Preclinical protein degradation biotech Kymera Therapeutics (KYMR) upsized and priced above the range to raise $174 million at a $938...read more
Software SPAC Software Acquisition Group III prices $200 million IPO
Software Acquisition Group III, the third blank check company led by former Ooyala officers targeting a software company, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-half of a warrant,...read more
Software Acquisition II, tech exec Jonathan Huberman's second SPAC, prices $150 million IPO at $10
Software Acquisition Group II, the second blank check company led by former Ooyala officers targeting a software company, raised $150 million by offering 15 million units at $10. Each unit consists of one share of the common stock and one-half of one...read more
13 companies file to list on Monday: IPO market set to explode after Labor Day
The IPO market is in for a busy fall. ...read more
US IPO Weekly Recap: Biotechs and SPACs ride the summer wave in a 4 IPO week
Three drug developers and a medical imaging company went public this past week, joined by eight SPACs. Preclinical protein degradation biotech Kymera Therapeutics (KYMR) upsized and priced above the range to raise $174 million at a $938...read more